ArticleBritish journal of cancer2013

Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling.

J Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.